![]() | |
Names | |
---|---|
IUPAC name
[3-[1-(Dimethylamino)ethyl]phenyl] N-methylcarbamate | |
Identifiers | |
3D model (JSmol) |
|
ChemSpider |
|
KEGG |
|
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
| |
| |
Properties | |
C12H18N2O2 | |
Molar mass | 222.288 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). |
Miotine is an anticholinesterase drug. Miotine was the first synthetic carbamate that was used clinically.[1]
Unlike the miotine analog neostigmine, it doesn't have a quaternary ammonium group to give it a permanent positive charge. It can exist as an uncharged free base which could allow it to cross the blood–brain barrier and cause unwanted central nervous system (CNS) side effects.[2]
{{cite web}}
: CS1 maint: archived copy as title (link)
![]() | This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |